-
Part 1 | Session 2 2 Trials That Will Change My Practice with Prof Rasha Al-Lamee
-
Part 1 | Session 3 3 Ways AI Will Change Your Practice
-
Part 1 | Session 4 TCT 25 Structural Interventions Highlights
-
Part 2 | Session 1 SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
-
Part 2 | Session 4 TRILUMINATE Pivotal Trial: Lessons Learned from Tricuspid TEER
-
Part 2 | Session 5 Real-World EVOQUE Outcomes from TVT Registry
-
Part 2 | Session 6 PASCAL Precision System in Complex Degenerative MR
-
Part 2 | Session 7 PREVUE-VALVE: Prevalence of Valvular Heart Disease in Older Americans
-
Part 2 | Session 9 Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
-
Part 2 | Session 10 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
-
Part 2 | Session 11 1-Year ENCIRCLE TMVR Results with SAPIEN M3
TCT 2025 - Dr Mirvat Alasnag (King Fahad Armed Forces Hospital, SA) reviews the most impactful late-breaking trials in structural cardiology, coronary interventions, and AI from TCT 2025.
Key trials:
0:40 – SUMMIT MAC (Tendyne TMVR in MAC)
2:25 – PARTNER 3 (7-year TAVR outcomes)
4:10 – CONFIRM 2 AI & angiography-derived physiology
6:05 – SHORTCUT (IVL vs cutting balloon)
7:45 – VICTORY (OPN vs IVL)
Editor: Mirjam Boros, Jordan Rance
Videogrphers: Tom Green, Dan Brent
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay Updated with Our TCT 2025 Video Coverage
We’re bringing you independent, critical insights straight from TCT 2025.
Join Prof Nicolas Van Mieghem in Cardiology Conference Perspectives as he discusses what the late-breaking data could mean for your practice.
Don’t miss our short Expert Interviews with investigators, offering concise analyses and practical take-home messages.
Hear Dr Mirvat Alasnag and Dr Rasha Al-Lamee share their views on the data they believe will have the greatest impact on clinical practice.
Follow the hot topics driving innovation in interventional cardiology, and stay tuned for fresh perspectives, real-world insights and global viewpoints, all coming soon on Transcatheter Academy.
More from this programme
Part 1
Highlights
Part 2
Expert Interviews
Part 3
NVM Cardiology Conference Perspectives
A focused video series where Prof Nicolas Van Mieghem offers expert reflections on the most impactful late-breaking trials shaping interventional cardiology at TCT 2025.
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.
Academic History
Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…
Comments